Agenus (AGEN) financial statements

Healthcare · Biotechnology · Market cap $330M

Agenus reported revenue of $114M in fiscal 2025, up 19.7% a year over 9 years.

Net income was -$101,000 and the operating margin -17.7%, against -476.1% in 2016.

Free cash flow was -$77M.

The diluted share count fell 99% over the period (buybacks).

Revenue and free cash flow

Fiscal years, $ billions.

-0.4-0.200.20.42016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Agenus's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$23M$43M$37M$150M$88M$296M$98M$156M$103M$114M
Cost of revenue————$2M$3M$11M$3M$486,000$1M
Gross profit————$86M$292M$87M$153M$103M$113M
Research and development$95M$116M$125M$168M$143M$179M$187M$235M$156M$79M
Selling, general and admin$33M$34M$37M$46M$59M$76M$81M$79M$72M$54M
Operating income-$107M-$104M-$124M-$70M-$117M$26M-$179M-$160M-$120M-$20M
Interest expense$19M$31M————$64M$104M$120M$56M
Pre-tax income-$127M-$121M—————-$257M-$232M-$3M
Income tax$0$0$0$0$0$0$0$0$0$0
Net income-$127M-$121M-$160M-$108M-$181M-$24M-$220M-$246M-$227M-$101,000
EPS (diluted)-$0.03-$0.02-$0.03-$0.02-$0.02$-0.00-$15.64-$13.75-$10.59$0.00
Diluted shares4.35B4.92B5.54B6.75B8.63B11M14M18M21M30M
Gross margin————97.3%98.8%89.2%98.0%99.5%99.1%
Operating margin-476.1%-242.1%-336.6%-46.7%-133.0%8.7%-183.0%-102.1%-116.4%-17.7%
Net margin-562.6%-281.5%-434.7%-71.9%-205.4%-8.2%-224.7%-157.4%-219.8%-0.1%

Balance sheet

Fiscal years, from Agenus's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$76M$60M$53M$62M$100M$307M$193M$76M$40M$3M
Receivables$11M$1M$938,000$16M$1M$2M$3M$26M$407,000$2M
Inventory$88,200$79,491$55,000$0——————
Total current assets$91M$74M$75M$87M$114M$332M$213M$112M$46M$133M
Property, plant and equipment$26M$26M$25M$26M$27M$60M$133M$133M$120M$15M
Goodwill$22M$23M$23M$23M$25M$25M$25M$25M$24M$24M
Total assets$157M$138M$136M$155M$215M$466M$414M$314M$226M$227M
Total current liabilities$41M$56M$68M$122M$130M$157M$189M$256M$221M$323M
Long-term debt$131M$142M$13M$13M$19M$13M$13M$13M$30M$0
Total liabilities$196M$214M$311M$387M$426M$418M$468M$462M$533M$505M
Shareholders' equity-$39M-$76M-$172M-$225M-$204M$34M-$61M-$160M-$326M-$271M
Net debt$59M$103M-$40M-$48M-$80M-$278M-$166M-$63M-$7M$42M

Cash flow

Fiscal years, from Agenus's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow-$80M-$94M-$131M-$19M-$139M$10M-$175M-$224M-$158M-$77M
Capital spending$13M$3M$4M$5M$3M$34M$53M$10M$576,000$6,000
Free cash flow-$92M-$97M-$135M-$23M-$143M-$24M-$228M-$234M-$159M-$77M
Stock-based compensation$13M$12M$8M$10M$10M$20M$18M$23M$17M$14M
Net borrowing—$15M-$162M—$5M-$462,000———-$2M
Free cash flow margin-409.7%-227.0%-366.2%-15.6%-161.7%-8.0%-233.0%-149.8%-153.6%-67.6%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AGEN.
Open AGEN in Investingly

Questions

What was Agenus's revenue in 2025?

$114M in fiscal 2025, from its 10-K filing.

How much free cash flow does Agenus generate?

-$77M in fiscal 2025 (operating cash flow minus capital spending).

From Agenus's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.